Novo Integrated Sciences, Inc.
NVOS
$0.01
$0.000.00%
OTC PK
| 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | 08/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.17M | -24.33M | -12.08M | -13.96M | -13.21M |
| Total Depreciation and Amortization | 2.26M | 2.28M | 2.30M | 2.29M | 2.30M |
| Total Amortization of Deferred Charges | 6.57M | 5.47M | 2.72M | 4.34M | 4.76M |
| Total Other Non-Cash Items | 3.46M | 11.46M | 3.59M | 4.17M | 3.45M |
| Change in Net Operating Assets | -1.20M | 373.40K | -1.48M | -954.60K | 460.60K |
| Cash from Operations | -5.07M | -4.75M | -4.95M | -4.12M | -2.24M |
| Capital Expenditure | -5.00K | -32.40K | -49.30K | -49.30K | -49.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -5.00K | -32.40K | -49.30K | -49.30K | -49.30K |
| Total Debt Issued | 8.65M | 9.02M | 4.38M | 4.83M | 1.52M |
| Total Debt Repaid | -3.90M | -3.75M | -352.90K | -509.00K | -3.08M |
| Issuance of Common Stock | 240.40K | 322.00K | 642.00K | 773.00K | 2.33M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.99M | 5.59M | 4.67M | 5.09M | 763.80K |
| Foreign Exchange rate Adjustments | 512.30K | 274.30K | 375.70K | -166.20K | -233.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 428.20K | 1.08M | 42.00K | 761.30K | -1.76M |